Funxional Therapeutics' Series B Round

Funxional Therapeutics raised a round of funding on May 07, 2010.

Funxional Therapeutics Ltd.'s focus is on broad-spectrum chemokine inhibitors. Its small molecule lead candidate has entered clinical development. The chemokine inhibitors will target a broad range of…

Articles about Funxional Therapeutics' Series B Round: